Last week the US Food and Drug Administration (FDA) granted approval for the biotechnological company Sarepta to market the drug eteplirsen.
This drug is the first effective treatment for the devastating disease, Duchenne Muscular Dystrophy, a fatal muscle wasting disease which affects 1 in 3500 boys, and is the culmination of two decades of research led by West Perth Rotary member Prof Steve Wilton and Prof Sue Fletcher.Read more...
Do you want to make a difference ? ask about joining Rotary
Phone Joseph on 0406943074
Have you "liked" us on Facebook yet?
Leederville Sporting Club, 78 Cambridge St Leederville, Western Australia 6007
Every Thursday 7:00 am to 8:30am
Date: Thursday Nov 3, 2016, 7:00 am
Mrs Hayley Lethlean
CEO Muscular Dystrophy WA
and Rotary West Perth Member
Muscular Dystrophy WAView ...